SKIN ELEMENTS LIMITED — Regulatory Filings 2021

Jan 17, 2021

18 January 2021

Vanessa Nevjestic Adviser, Listings Compliance (Perth) Australian Stock Exchange Limited Level 40, Central Park, 152-158 St George's Terrace PERTH WA 6000

By email: listingscomplianceperth@asx.com.au

Dear Vanessa

We refer to your letter dated 15 January 2021 regarding an ASX price and volume query and respond to your questions as follows:

1. Is SKN aware of any information concerning it that has not been announced to the market which, if known by some in the market, could explain the recent trading in its securities?

The Company is not aware of any information concerning it that has not been announced to the market which, if known, could explain the recent trading in the securities of the Company.

• 2. Not applicable
• 3. If the answer to question 1 is "no", is there any other explanation that SKN may have for the recent trading in its securities?

The Company refers to recent news flow on 11 November 2020 in which it announced that that it had submitted its application for Therapeutic Goods Administration (TGA) listing of its new formulation Invisi Shield® Organics (Invisi Shield®) as a natural disinfectant product, and the shortfall notice in respect of the Options Underwriting Agreement with State Securities, as announced on 12 January 2021. As set out in the announcement on 12 January 2021, and pursuant to the Options Underwriting Agreement dated 16 April 2020, the Company has notified State Securities Pty Ltd (Underwriter) of the number of Shortfall Securities. The Company expects to receive the shortfall funds from, and subsequently to issue the new shares to, the Underwriter (or any sub-underwriters) on 22 January 2021. The shares will be issued in accordance with ASX Listing Rule 7.2 (Exception 10) and the Corporations Act.

4. Please confirm that SKN is in compliance with the Listing Rules and, in particular, Listing Rule 3.1.

The Company confirms that it is in compliance with the Listing Rules and, in particular, Listing Rule 3.1.

5. Please confirm that SKN's responses to the questions above have been authorised and approved in accordance with its published continuous disclosure policy or otherwise by its board or an officer of SKN with delegated authority from the board to respond to ASX on disclosure matters.

The Company confirms that its responses to the questions above have been authorised and approved by an officer of the Company with delegated authority from the board to respond to the ASX on disclosure matters.

Yours sincerely

Steven Wood Joint Company Secretary

15 January 2021 Reference: ODIN29587

Mr Steven Wood Company Secretary Skin Elements Limited 1242 Hay Street West Perth, Western Australia 6005

By email: sw@grangeconsulting.com.au

Dear Mr Wood

Skin Elements Limited ('SKN'): Price and Volume Query

ASX refers to the following:

• A. The change in the price of SKN's securities from an intraday low of $0.100 to an intraday high of $0.120 at the time of writing this letter today.
• B. The significant increase in the volume of SKN's securities traded from 14 January 2021 to 15 January 2021.

Request for information

In light of this, ASX asks SKN to respond separately to each of the following questions and requests for information:

• 1. Is SKN aware of any information concerning it that has not been announced to the market which, if known by some in the market, could explain the recent trading in its securities?
• 1. If the answer to question 1 is "yes".
  • (a) Is SKN relying on Listing Rule 3.1A not to announce that information under Listing Rule 3.1? Please note that the recent trading in SKN's securities would suggest to ASX that such information may have ceased to be confidential and therefore SKN may no longer be able to rely on Listing Rule 3.1A. Accordingly, if the answer to this question is "yes", you need to contact us immediately to discuss the situation.
  • (b) Can an announcement be made immediately? Please note, if the answer to this question is "no", you need to contact us immediately to discuss requesting a trading halt (see below).
  • (c) If an announcement cannot be made immediately, why not and when is it expected that an announcement will be made?
• 1. If the answer to question 1 is "no", is there any other explanation that SKN may have for the recent trading in its securities?
• 1. Please confirm that SKN is complying with the Listing Rules and, in particular, Listing Rule 3.1.
• 1. Please confirm that SKN's responses to the questions above have been authorised and approved under its published continuous disclosure policy or otherwise by its board or an officer of SKN with delegated authority from the board to respond to ASX on disclosure matters.

When and where to send your response

This request is made under Listing Rule 18.7. Your response is required as soon as reasonably possible and, in any event, by no later than 2.30 PM AWST today, Friday, 15 January 2021. You should note that if the information requested by this letter is information required to be given to ASX under Listing Rule 3.1 and it does not fall within the exceptions mentioned in Listing Rule 3.1A, SKN's obligation is to disclose the information 'immediately'. This may require the information to be disclosed before the deadline set out in the previous paragraph and may require SKN to request a trading halt immediately.

Your response should be sent to me by e-mail at ListingsCompliancePerth@asx.com.au. It should not be sent directly to the ASX Market Announcements Office. This is to allow me to review your response to confirm that it is in a form appropriate for release to the market, before it is published on the ASX Market Announcements Platform.

Trading halt

If you are unable to respond to this letter by the time specified above, or if the answer to question 1 is "yes" and an announcement cannot be made immediately, you should discuss with us whether it is appropriate to request a trading halt in SKN's securities under Listing Rule 17.1. If you wish a trading halt, you must tell us:

• the reasons for the trading halt;
• how long you want the trading halt to last;
• the event you expect to happen that will end the trading halt;
• that you are not aware of any reason why the trading halt should not be granted; and
• any other information necessary to inform the market about the trading halt, or that we ask for.

We require the request for a trading halt to be in writing. The trading halt cannot extend past the commencement of normal trading on the second day after the day on which it is granted. You can find further information about trading halts in Guidance Note 16 Trading Halts & Voluntary Suspensions.

Suspension

If you are unable to respond to this letter by the time specified above, ASX will likely suspend trading in SKN's securities under Listing Rule 17.3.

Listing Rules 3.1 and 3.1A

In responding to this letter, you should have regard to SKN's obligations under Listing Rules 3.1 and 3.1A and also to Guidance Note 8 Continuous Disclosure: Listing Rules 3.1 – 3.1B. It should be noted that SKN's obligation to disclose information under Listing Rule 3.1 is not confined to, nor is it necessarily satisfied by, answering the questions set out in this letter.

Release of correspondence between ASX and entity

We reserve the right to release a copy of this letter, your reply and any other related correspondence between us to the market under Listing Rule 18.7A.

Questions

If you have any questions in relation to the above, please do not hesitate to contact me.

Yours sincerely

Vanessa Nevjestic Adviser, Listings Compliance (Perth)